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ABSTRACT We observed intense intracellular immunofluorescence of rat lung fibroblasts
stained with hybridoma culture supernatant containing monoclonal antibodies to human
plasma fibronectin, but no pericellular matrix staining. Immunoprecipitation and absorption
experiments revealed that this intracellular staining by hybridoma-conditioned medium was
due to binding of fibronectin-antifibronectin immune complexes via the fibronectin to intra-
cellular procollagen. The anomalous staining patterns we encountered were not revealed by
the usual controls for immunohistochemical specificity, and also occurred in rat tissue sections.
This general phenomena-binding of serum antigens present in hybridoma medium to cellular
components-could in principle result in artifactual staining with monoclonal antibodies to
other serum components, so investigators using monoclonal antibodies should be aware of
this new artifact. Our results also demonstrate that fibronectin binds specifically to native
procollagen . Monoclonal antibodies may be useful for studying fibronectin-procollagen and
other macromolecular interactions.
Monoclonal antibodies (7) are powerful tools for cell biolo-
gists, but their use may be accompanied by unusual pitfalls.
For example, it is well documented that monoclonals may
bind genetically distinct polypeptides (8). Using hybridoma
culture medium containing monoclonal antibody to human
fibronectin (FN)' to stain rat lung fibroblasts (RLF), we
encountered a previously unreported artifact. Monoclonal
antifibronectin-fibronectin complexes bound to intracellular
collagenase-sensitive ligands, presumably procollagen, result-
ing in intense intracellular immunofluorescence. As mono-
clonals are often used in the form of conditioned medium
from serum-containing hybridoma cultures, this general phe-
nomena is important to recognize as a potential artifact of
monoclonal antibody staining. Our findings also have impli-
cations for fibronectin interactions with procollagen, which
are briefly discussed.
MATERIALS AND METHODS
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Immunoreagents and FN: Monoclonal antibodies to human
'Abbreviations used in thispaper:
￿
FITC, fluorescein isothiocyanate;
FN, fibr6nectin; RLF, rat lung fibroblasts.
plasmaFN were obtained by fusingspleen cells from immunized BALB/c mice
with SP2/O-Ag 14 myeloma cells (19). Positive fusionswerecloned in soft agar
and antibody-secreting clones detectedby enzyme-linked immunosorbent assay
(4). Hybridomas were expanded in cell culture using DME plus 10% agam-
maglobulinemic horse serum, 5% calf serum, and nonessential amino acids
("hybridoma medium"). Ascites fluid containing 2-5 mg/ml of IgG was ob-
tained by intraperitoneal injection of 106 myeloma cells into pristane primed
BALB/c mice followed by paracentesis after 1-2 wk. Ascites was clotted at
25°C for 1 h, centrifuged (1,000 g, 10 min), protease inhibitors (I mM
phenylmethylsulfonylfluoride, 1 mM N-ethylmaleimide, 10 mM EDTA) and
0.02% NaN3 were added, and the supernate ("ascites") stored at -20°C. In
some experiments IgG monoclonals were purified by affinity chromatography
on FN-Sepharose. Humanplasma FN, rat plasma FN, andhybridoma medium
FN (from the horse and calf serum) were purified by gelatin-affinity chroma-
tography (11). For maximal purity, the human plasma FN was furtherpurified
on an IgG monoclonal antibody to human plasma FN coupled to Sepharose-
4B. For absorption experiments, conditioned hybridoma medium or ascites
fluid (1/100 dilution) was incubated with 1 mg/ml purified FN for 2 hat 37°C,
centrifuged (10,000 g, 5 min) and the supernatant used for staining. Polyclonal
rabbit anti-human plasma FN IgG was affinity-purified as described (12, 20).
FN absorption ofpolyclonal anti-FN was performed as above, with a 5:1 molar
ratio of FN/IgG, using440 kilodalton (kd) and 150 kd for FN and IgG.
Cell Culture, Metabolic Labeling and Immunoprecipita-
tion:
￿
Rat lung fibroblasts were obtained from trqpsin digests of minced
lungs of 21-d Sprague-Dawley rat embryos and maintained in RPMI-1640
containing 25 ag/ml ascorbic acid and 10% fetal bovine serum depleted of
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used within five subcultivations (1 :3 split ratio) and maintained typical fibro-
blastic morphology. These cells stained uniformly for intracellular and matrix
FN with polyclonal anti-FN IgG (see below).
Metabolic labeling with ["C]proline was carried out using serumless proline
free RPMI (20). For immunoprecipitation, protease inhibitors and Tris-HCI
buffer (pH 7.5, 20 mM final concentration) were added to the medium. The
cell layer was rinsed, and cells lysed in 1 % sodium deoxycholate in 20 mM
Tris-HCI, 140 mM NaCl, pH 7.5 containing protease inhibitors. Medium and
cell lysates were centrifuged at 18,000 g for 30 min at 25°C and 250 Al of
supernatant immunoprecipitated by adding equal volumes of conditioned
hybridoma medium or ascites (1:100 diluted). After incubation for 2 h at 37°C,
125 tug ofrabbit-anti-mouse immunoglobulin (Cappel Laboratories, Cochran-
ville, PA) was added, andthe mixture incubated for 1 h. Then, 50,I ofa 10%
suspension of killed, fixed Cowan strain S. aureus (IGSORB; The Enzyme
Center, Boston, MA) was added, the mixture incubated for 30 min at 37°C,
bound immunoglobulin complexes pelleted at 10,000 g for 5 min and rinsed
with three cycles ofvortexing andsedimentation in 50 mM HEPES-140 mM
NaCl containing protease inhibitors, 1% sodium deoxycholate, and 1% Tween-
20, pH 7.5. Immunoprecipitation with polyclonal IgG anti-FN was carried out
similarily using 25 jug of purified anti-FN or preimmune IgG. The rinsed
IGSORB was suspended in 75 pl of SDS-sampel buffer containing 50 mM
dithiothreitol, heated (100°C, 5 min), centrifuged at 10,000 gfor 1 min, and
the supernate removed and analyzed by SDSPAGE and fluorography (20).
Immunofluorescence Staining:
￿
Rat lung fibroblasts were fixed
with 3.5% paraformaldehyde, pH 7.4, and rinsed in Tris-buffered saline, pH
7.4, containing 1 mg/ml ofheat-denatured bovine serum albumin. Cells were
permeabilized with I % Triton X-100 in Tris-buffered saline for 5 min. Subse-
quent staining steps (e.g., hybridoma-conditioned medium followed by fluores-
cein isothiocyanate (FITC)-labeled rabbit anti-mouse IgG)(Miles Laboratories,
Elkhart, IN) were carried out for 30 minat 25°C, followed by three rinses of 5
mineach in Tris-bufferedsaline containing bovine serum albumin. Slides were
mounted in Tris-buffered saline containing 1 mg/ml of p-phenylene-diamine,
pH 8.0, to prevent FITC bleaching. Complete details of our immunofluores-
cence protocols have been given previously (13).
RESULTS
Immunofluorescence Results
This artifact was discovered by screening hybridoma-con-
ditioned medium containing anti-human plasma FN mono-
clonals for reaction with rat diaphragm cryostat sections (17).
7 of 35 hybridoma culture supernates cross-reacted with rat
diaphragm, but gave a qualitatively different pattern than
polyclonal anti-FN. By ELISA, all bound to the elastase-
released, carboxy terminal 140,000 mol wt fragment of FN.
When we stained IMR-90 human lung fibroblasts with these
hybridoma-conditioned media, the results were identical to
results obtained with polyclonal anti-FN (cf. reference 17).
However, staining of RLF with hybridoma-conditioned me-
dia resulted in exclusively intracellular, intense granular peri-
nuclear staining (Fig. 1, A and B), whereas polyclonal anti-
FN resulted in characteristic pericellular matrix and intracel-
lular FN staining (Fig. 1, C and D). When RLF were not
permeabilized before incubation with hybridoma-conditioned
media, no staining resulted.
To elucidate the cause of this unusual staining pattern of
RLF by hybridoma-conditioned medium, we performed a
series of immunostaining experiments. The following results
suggested that serum-derived FN in the hybridoma-condi-
tioned medium was responsible for the staining: (a) Ascites
fluid containing the hybridoma antibodies did not stain RLF,
but addition of human plasma FN to the ascites resulted in
intracellular fluorescence identical to that observed with
hybridoma-conditioned medium. (b) Mixing ascites with FN
purified from hybridoma medium also gave intracellular
staining identical to that observed with hybridoma-condi-
tioned medium. (c) Ascites mixed with FN-depleted
hybridoma medium did not stain RLF; addition of FN puri-
fled from the hybridoma medium to the hybridoma medium-
ascites mixture restored staining. (d) The exclusively intracel-
lular staining of RLF could be reporduced by staining with a
mixture of pure human plasma FN in antigen excess to
affinity-purified polyclonal anti-human plasma FN.
The immunostaining results suggested that FN-anti-FN
monoclonal IgG complexes were binding to intracellular lig-
ands in fixed, permeabilized RLF. Moreover, based upon
immunostaining with ascites or purified antibodies, the mon-
oclonal antibodies to human plasma FN did not cross-react
with rat FN. Enzyme digestion experiments carried out on
permeabilized and nonpermeabilized cells suggested that col-
lagenous components were the intracellular ligands responsi-
ble. Bacterial collagenase devoid of nonspecific proteinase
activity (Sigma Type VII, 150 U/ml for 1 h at 37°C)abolished
staining with hybridoma-conditioned medium. Neither chon-
droitinase ABC (Miles Laboratories, 5 U/ml, 37°C, 1 h) nor
testicular hyaluronidase (Sigma Chemical Co., St. Louis, MO;
1 mg/ml, 37°C, 1 h) affected staining. Thus, collagenase-
sensitive intracellular ligands appeared to be binding FN-
anti-FN complexes.
Immunoprecipitation Experiments
Binding of collagenous components to FN-anti-FN com-
plexes was confirmed by a series of immunoprecipitation
experiments using metabolically labeled RLF cell lysates and
culture medium with polyclonal antibodies, ascites, or
hybridoma-conditioned medium. Representative results are
depicted in Figs. 2 and 3. Fig. 2, lane A is a fluororogram of
["C]proline-labeled proteins secreted by RLF. FN and two
major chains co-migrating with purified pro-al(I) and pro-
a2(I) (PC) are indicated. Lane B shows the same sample after
bacterial collagenase digestion. Note that FN is not degraded,
and two additional polypeptides migrating close to the pro-
al(I) chain are revealed. Immunoprecipitation of A with
polyclonal anti-FN yields only FN (lane C), while preimmune
IgG precipitates no labeled polypeptides (lane D). This exper-
iment indicates that the clostridial collagenase we used is free
of FN degrading activity, the polyclonal anti-FN precipitates
only FN, and the majority of ["C]proline-labeled polypep-
tides secreted by rat lung fibroblasts are collagenous.
Fig. 3 shows the results ofa similar experiment using ascites
fluid containing monoclonal antibody to human plasma FN.
Lane A displays the total ["C]proline-labeled medium poly-
peptides from RLF. Polyclonal anti-FN immunoprecipitates
the small amount of FN present, as well as small amounts of
other polypeptides (lane B). Neither preimmune IgG (lane C)
nor ascites containing monoclonal antibody to human FN
(lane D) precipitated rat FN. Addition of human plasma FN
in antigen excess to the ascites precipitated a number of
labeled polypeptides (lane E), all of which were sensitive to
bacterial collagenase (lane F). The two major polypeptides
were of apparent mol wt 162,000 and 140,000, corresponding
to the size of authentic purified procollagen type I chains. By
densitometric scanning (across the narrowest dimension of
the precipitated polypeptides to avoid errors introduced by
differing widths of lanes), we estimated that at least 60% of
the total ["C]proline-labeled polypeptides in medium were
precipitated by the monoclonal antibody-FN mixture. The
two major labeled polypeptides were present in a ratio of
1 .7:1 . As shown in lane F, pepsin treatment converted the
precipitated collagenous peptides to two major polypeptides
migrating with apparent mol wt 140,000 and 130,000. These
McDONALD AND KELLEY
￿
New Pitfall in Immunostaining
￿
1043FIGURE 1
￿
Immunofluorescence staining of permeabilized rat lung fibroblasts with hybridoma conditioned medium or polyclonal
antifibronectin IgG . The same field is shown by phase contrast and fluorescence. (A and B) Stained with hybridoma conditioned
medium . Note the intense intracellular staining and total absence of pericellular matrix staining . (C and D) Stained with affinity
purified antibodies to human plasma fibronectin . Despite lower cell density than in A, there is obvious pericellular matrix as well
as intracellular staining. (E and F) are Triton-permeabilized cells incubated with purified bacterial collagenase (100 tag/ml, 10 min,
37°C) followed by rinsing and staining as in A and B.Note than only faint nonspecific nuclear fluorescence is seen, indistinguishable
from cells incubated with second antibody alone . Bar in A, 50 lam . x 300 .
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human type I a, and a 2 chains. We have displayed results
obtained with RLFmedium for illustrative purposes, although
similar results were obtained with cell lysates . On the basis of
similar molecular weights, collagenase sensitivity, pepsin re-
sistance of a-chain sized digestion products of larger precur-
sors, and the fact that fibroblastic cells synthesize procollagens
I and III, we tentatively identify these two major polypeptides
precipitated by FN-anti-FN complexes as procollagen type I
and possibly III a-chains. Obviously further biochemical con-
firmation is required, although little doubt concerning their
collagenous identity remains.
Thus, a mixture of monoclonal antibody to human plasma
FN with FN immunoprecipitated collagenous polypeptides,
which appeared to be primarily type I procollagen . Identical
results were obtained with serum-containing hybridoma cul-
ture medium (not shown) . To determine whether this pattern
ofprecipitation could be duplicated by other antigen-antibody
combinations, we performed additional experiments. First,
we reproduced the precipitation experiments substituting pol-
yclonal anti-FN for the monoclonal antibody and adding
excess FN. This mixture precipitated the same collagenous
polypeptides as the monoclonal antibody-antigen mixture .
Second, neither preimmune IgG nor a SP2-derived mono-
clonal antibody to bovine elastin (generously provided by Dr .
Robert Mecham, Washington University Medical School)
precipitated collagenase-sensitive polypeptides from rat lung
fibroblast medium or cell lysate when compared with preim-
mune or no primary antibody controls . Third, addition of
excess FN to these control antibodies also did not result in
significant precipitation.
FIGURE 2 Immunoprecipitation of ['°C]proline labeled rat lung
fibroblast culture medium with polyclonal antifibronectin . This is a
fluorogram of a 7.5% PAGE . Lane A is the total polypeptides, with
the fibronectin ("FN") and two major polypeptides co-migrating
with purified type I procollagen ("PC") indicated . Lane B shows the
result of digesting the sample in A with purified Clostridial collagen-
ase . Note that protease-sensitive FN is spared, and two minor bands
migrating at approximately the position of pro-a,([) are revealed .
Lane C is an immunoprecipitate of the sample in lane A with
polyclonal anti-FN antibody, while laneD is a corresponding control
with preimmune serum .
FIGURE 3 Immunoprecipitation of [' °C]proline labeled rat lung
fibroblast culture medium with polyclonal antifibronectin . This is a
fluorogram of an SDS 5% PAGE, and the fibronectin (FN) and
procollagen type I a-chains (PC) are indicated as in Fig. 2 . Lane A
displays the total secreted labeled polypeptides . Note that FN
constitutes a relatively minor component of the secreted, proline-
labeled material, most remaining associated with the cell layer (not
shown) . Lane B is an immunoprecipitate of A with polyclonal anti-
FN, lane C is a polyclonal preimmune control, and lane D is an
immunoprecipitate with ascites containing anti-human FN mono-
clonal antibody . There is some nonspecific precipitation of labeled
polypeptides corresponding to the major ones in C and D, but no
detectable FN . Lane E demonstrates the results of mixing the same
concentration of ascites used in lane D with excess human plasma
FN . A number of polypeptides are precipitated, with two major
components corresponding to the major proline-labeled bands in
the medium . Collagenase digestion of the sample in lane E removes
all of the labeled polypeptides, while pepsin digestion (lane G)
converts them to two major bands corresponding in size to a-chains
of type I collagen .
With these immunoprecipitation results in hand, we per-
formed two additional staining experiments to determine
which component of the immune complexes (i.e ., FN or
immunoglobulin) was binding to intracellular ligands. In the
first experiment, fixed and permeabilized RLF were incubated
with 100 Ag/ml of human plasma FN for 1 h at 37 °C, rinsed
extensively, and then incubated with ascites followed by
FITC-conjugated second antibody (incubation with ascites
followed by second antibody did not give intracellular stain-
ing) . These cells exhibited intense intracellular fluorescence
identical to RLF stained with hybridoma-conditioned me-
dium, demonstrating that dimeric human plasma FN bound
to intracellular ligands in the fixed and permeabilized RLF .
In the second experiment, we attempted to block putative
procollagen binding sites on FN by incubating a mixture of
ascites and FN with pure heat-denatured type I collagen (2:1
molar ratio of collagen to FN, using 100,000 mol wt for
collagen and 220,000 for FN) for I h before addition to
permeabilized RLF. This blocked subsequent intracellular
fluorescence staining with ascites followed by FITC-conju-
gated second antibody .
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(2) McAb-FN + PCOL - McAb-FN-PCOL
(3) GAM + McAb-FN-PCOL - GAM-MCAb-FN-PCOL
FIGURE 4
￿
Schematic representation of the nonimmunologic inter-
action of fibronectin immune complexes with intracellular procol-
lagen. Step 1 depicts the bindingof monoclonal antibodies (McAb)
to fibronectin (FN) to form an immune complex. In our initial
experiments, this step occurred during culture of the monoclonals
in serum (and thus FN) containing medium. Step 2 depicts the
binding of monoclonal antibody-FN complexes to procollagen
(PCOL) via the FN to form a monoclonal anti body-FN-procollagen
complex. In step 3, the monoclonal antibody is bound by a second
antibody, in this case a goat-antimouse (GAM) to yield the final
complex. If the second antibody is FITC-conjugated, intense intra-
cellular fluorescence results (see Fig. 1). In principle, this type of
interaction could occur with any serum component capable of
binding to cellular or secreted antigens.
Based upon the immunoprecipitation and staining experi-
ments, we conclude that "soluble" (the complexes were not
centrifuged at sufficientforce to use this term as operationally
defined) immune complexes of monoclonal or polyclonal
antibody with FN, either formed in hybridoma-conditioned
medium from FN present in the sera, or created by adding
purified FN to ascites fluidor to polyclonal anti-FN IgG, bind
to intracellular collagenous components in rat lung fibroblasts
via the FN portion of the immune complex. The resulting
antibody-collagen complex binds FITC-conjugated second
antibody, resulting in intracellular staining. This scheme is
depicted in Fig. 4.
DISCUSSION
We encountered a new artifact resulting from the use of
hybridoma conditioned medium forimmunostaining. By cus-
tomary immunohistochemical criteria, the intracellular stain-
ing of RLF by hybridoma-conditioned medium appeared
specific. Appropriately negative controls included no staining:
(a) with second antibody alone; (b) with hybridoma medium
alone followed by second antibody; or (c) with hybridoma-
conditioned medium absorbed with rat plasma FN (this was
presumably due to the rat plasma FN blocking intracellular
collagenous binding sites for IN but not being bound by the
monoclonal antibodies). The only clue to the artifact was the
difference in the distribution of tissue staining between poly-
clonal and monoclonal antibodies.
This artifact is potentially important, as inspection of Fig.
4 reveals that it could occur in any situation in which
hybridoma culture medium contains serum antigens that
cross-react with a monoclonal antibody and also bind to
cellular or tissue ligands. Possible candidates include many
serum components such as immunoglobulins and comple-
ment factors. Thus, monoclonal antibody staining, especially
using hybridoma-conditioned medium in heterologous sys-
tems, may be subject to new artifacts of which investigators
should be aware (see also reference 8).
Apart from revealing a troublesome immunochemical ar-
tifact, our demonstration ofintracellular collagenous binding
sites for human plasma and cell secreted FN in RLF raises
questions aboutFN-procollagen interaction. Collagen and FN
most likely share a spacially common secretory pathway, at
leastto the levelofthe Golgi (6, 10, 15), and evidence supports
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significant interactions between these matrix components in
the extracellular space (c.f. reference 13). Yet, it seems un-
likely that intracellular FN-procollagen binding occurs under
physiologic conditions, as large multimers hindering transcel-
lular movement could result. Thus, specific regulatory mech-
anisms may operate to prevent intracellular assembly. Of
course, we may simply have circumvented these by fixation
and permeabilization. However, alternative possibilities could
account for our results. First, FN multimers, resulting in our
experiments from antibody binding and physiologically by
assembly in the extracellular milieu may have higher avidity
for procollagen. This has been previously demonstrated for
FN-binding to heparin and hyaluronate (9), and a ternary
complex between FN, procollagen(s), and heparan sulfate
proteoglycan may be required for tight binding. Posttransla-
tional modifications of FN may function to limit binding to
procollagen during synthesis and before secretion. FN is syn-
thesized with asparagine-linked, mannose-rich carbohydrate
side chains located on the gelatin binding domain. These high
mannose oligosaccharides are replaced with the complex form
before secretion (2, 16). As the carbohydrates render FNs
collagen binding domain protease resistant and are not re-
quired for its secretion by fibroblasts, protease resistance has
been speculated to be one of their functions (1). However,
replacement ofthe high mannose with the complex side chain
might allow procollagen binding, or FN-FN interaction,
which may also be localized to this domain (13). It would be
necessary to test binding of the intracellular high mannose
form of FN to native procollagen to test this hypothesis.
Previously, it has been observed that plasma fibronectin is
rapidly incorporated into the pericellular matrix of cultured
fibroblasts (5, 14). However, formalin-fixed RLF pericellular
matrix did not decorate with FN-anti-FNimmune complexes
during a 30-min incubation. This does not contradict previous
studies, as we could easily detect human plasma FN in the
deoxycholate insoluble pericellular matrix of RLF after co-
culturing for 24 h. Possibly, live cells are necessary for FN
incorporation, or the binding sites are sensitive to formalin
fixation. It may appear paradoxical that intracellular but not
pericellular matrix collagens bind human FN. However, re-
cent results from our laboratory suggest that collagenous
ligands are not responsible for FN binding to fibroblast peri-
cellular matrix. Moreover, it appears that FN is in excess to
collagen in matrix deposited early after subcultivation by
fibroblasts. For example, IMR-90 human lung fibroblast per-
icellular matrix contains free FN-derived binding sites for
FITC-labeled gelatin that are blocked by Fab' to the FN
gelatin-binding domain (reference 13, unpublished observa-
tions).
We hope that FN-antibody complexes of defined compo-
sition may be useful in studying the molecular basis of peri-
cellular matrix organization. Previously, we have not been
able to identify FN-procollagen interaction of reasonable
avidity using a variety of measures, including solid phase
derivatives such as FN-Sepharose and isolated gelatin-binding
domains of FN coupled to Sepharose. As Engvall and co-
workers (3) could readily demonstrate native type I collagen-
FN interaction using this method, procollagen-FN interaction
may be weaker. However, the demonstration of procollagen
binding to FN-anti-FNcomplexes together with our previous
study demonstrating inhibition of collagen matrix formation
with collagen binding domain specific antibodies suggests that
FN-procollagen interaction is physiologically relevant. Nota-bly, similar immune complexes have been used in the purifi-
cation of a cellular transferrin receptor, suggesting that this
technology may be generally useful for the study of macro-
molecular interactions (18).
Thomas J. Broekelmann and Patricia Prevedel of our laboratory
helped develop the monoclonal antibodies. Useful discussions and
data were provided by Drs. Arlene Chiu and Joshua R. Sanes,
Physiology and Biophysics, Washington University School of Medi-
cine, Dr. Edmond Crouch, Pathology Department and Dr. Joan
Clark, Pulmonary Division at the Washington University School of
Medicine.
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